Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
ACC/AHA (1996) Guidelines for the management of patients with acute myocardial infarction. JACC 28: 1328–1438
ACC/AHA (2002) Guideline update for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on assessment of cardiovascular procedures. Circulation 106:1883
ACC/AHA Task force report (1990) Guidelines for the early management of patients with acute myocardial infarction. J Am Coll Cardiol 16: 249–292
Achenbach S, Moshage W, Ropers D et al. (1998) Value of electron-beam computed tomography for the noninvasive detection of high grade coronary artery stenoses and occlusions. N Engl J Med 339: 1972–1978
Agatston AS, Janowitz WR, Hildner Fj et al. (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15: 827–832
AHA committee report (1975) A reporting system for coronary artery disease. Circulation 51: 5
AHA Medical/Scientific Statement. Fletcher GF, Balady G, Froelicher VF et al. (1995) Exercise Standards. Circulation 91: 580–615
AIRE Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821–828
American Heart Association (1992) Medical Scientific Statement, Guidelines for electrocardiography. Circulation 85: 1221–1228
American Heart Association/American College of Cardiology (1991) Guidelines for cardiac catheterization and cardiac catheterization laboratories. Circulation 84: 2213–2247
Anderson HV, Talley JD, Black AJR et al. (1990) Usefulness of coronary angioplasty in asymptomatic patients. Am J Cardiol 65: 35
Anderson HV, Cannon CP, Stone PH et al. (1995) One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIB clinical trial: a randomized comparison of tissue plasminogen activator vs. placebo and early invasive vs. early conservative strategies in unstable angina and non-q-wave myocardial infarction. J Am Coll Cardiol 26: 1643–1650
André-Fouet X, Pillot M, Leizorovicz A et al. (1989) Non Q-wave, alias nontransmural myocardial infarction: A special entity. Am Heart J 117: 892–901
Anistreplase Intervention Mortality Study (AIMS) (1988) Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction preliminary report of a placebo-controlled clinical trail. Lancet I: 546–549
Antiplatelet trialists collaboration (1994) in: BMJ 308: 81–106
Antman EM, TIMI 9B Investigators (1996) Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Circulation 94: 911–921
Antoniucci D, Santoro GM, Bolognese L et al. (1998) A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 31: 1234–1239
Armstrong SC, Latham CA, Shivell CL, Ganote CE (2001) Ischemic loss of sarcolemmal dystrophin and spectrin: correlation with myocardial injury. J Mol Cell Cardiol 33: 1165–1170
Auchampach JA, Gross GJ (1993) Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am J Physiol 264: H1327–H1336
Bartling B, Holtz J, Darmer D (1998) Contribution of myocyte apoptosis to myocardial infarction? Bas Res Cardiol 93: 71–84
Baumgart D, Ehring T, Krajcar M, Heusch G (1993) A proischemic effect of nisoldipine. Relation to a decrease in perfusion pressure and comparison to dipyridamole. Cardiovasc Res 27: 1254–1259
Bell MR, Reeder GS, Garratt KN et al. (1993) Predictors of major ischemic complications after coronary dissection following angioplasty. Am J Cardiol 71: 1402–1407
Berger PB, Ruocco NA, Ryan TJ et al. (1993) Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy. Am J Cardiol 71: 1148–1152
Berger PB, Tuttle RH, Holmes DR et al. (1999) One year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization. Circulation 99: 873
Bertrand ME, Lablanche JM, Leroy F et al. (1992) Percutaneous transluminal coronary rotary ablation with Rotablator (European experience). Am J Cardiol 69: 470–474
Bertrand ME, McFadden EP, Fruchart JC et al. (1997) Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. J Am Coll Cardiol 30: 863–869
Bertrand ME, Legrand V, Boland J et al. (1998) Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) Study. Circulation 98: 1597–1603
Bittl JA, Ryan TJ Jr, Keaney JF Jr et al. (1993) Coronary artery perforation during excimer laser coronary angioplasty. J Am Coll Cardiol 21: 1158–1165
Bleifeld W, Nienhaber CA (1990) Was ist entbehrlich in der Diagnostik der koronaren Herzkrankheit? Dtsch Med Wochenschr 115: 1201–1209
Boden WE, ORourke R, Crawford H et al. (1998) Outcomes in patients with acute non-q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 338: 1785–1792
Boer MJ de, Hoorntje JCA, Ottervanger JP et al. (1994a) Immediate coronary angioplasty vs. intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol 23: 1004–1008
Boer MJ de, Suryapranata H, Hoorntje JCA et al. (1994b) Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 90: 753–761
Böger A, Hort W (1977) Qualitative und quantitative Untersuchungen am Lymphgefäßsystem des Mauseherzens. Basic Res Cardiol 72: 510–529
Bolli R (1990) Mechanism of myocardial »stunning«. Circulation 82: 723–738
Bolli R (1992) Myocardial »stunning« in man. Circulation 86: 1671–1691
Bonnett JL, Bory M, DHoudain F et al. (1989) Association of tissue plasminogen activator and streptokinase in acute myocardial infarction: preliminary data. Circulation 80(Suppl II): II-343
Bredlau C, Roubin GS, Leimgruber PP et al. (1985) In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 72: 1044–1052
Buchbinder M, Leon M, Warth D et al. (1992) Multi-center registry of percutaneous coronary rotational ablation using the Rotablator. J Am Coll Cardiol 19: 333A
Büchner F (1932) Die Rolle des Herzmuskels bei der Angina pectoris. Beitr Pathol Anat 89: 644–667
Buchwald H, Varco RL, Matts JP et al. (1990) Effect of partial ilium bypass surgery on mortality and morbiditiy from coronary heart disease in patients with hypercholesterolemia: Report on the Program on the Surgical Control of the Hyperlipidemias (POSCH) N Engl J Med 323: 946–955
Burke AP, Kolodgie FD, Farb A et al. (2001) Healed plaque rupture and sudden coronary death. Evidence that subclinic rupture has a role in plaque progression. Ciculation 103: 934–940
Byington RP, Jukema W, Salonen WT et al. (1995) Reduction in cardiovascular events during pravastatin therapy: pooled analysis of clinical events of the pravastatin atherosclerosis intervention program. Circulation 92: 2419–2425
Bypass Angioplasty Revascularization Investigation (BARI) Investigators (1996) Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335: 217–225
CABRI Trial Participants (1995) First-year results of CABRI (Coronary Angiopalsty vs. Bypass Revascularisation Investigation). Lancet 346:1179–1184
Cairns JA, Gent M, Singer J et al. (1985) Aspirin, sulfinpyrazone or both in unstable angina. N Engl J Med 313: 1369–1375
Cairns JA, Conolly SJ, Roberts R, Gent M (1997) Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations. Lancet 349: 675–682
Califf RM, Topol EJ, Stack RS et al. (1991) Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction: the TAMI-5 randomized trial. Circulation 83: 1543–1556
Campeau L (1976) Grading of angina pectoris. Circulation 54: 522
Cannon CP, McCabe CH, Henry TD for the TIMI-5 Investigators (1993) Hirudin reduces reocclusion compared to heparin following thrombolysis in acute myocardial infarction:results of the TIMI-5 Trial. J Am Coll Cardiol 2(Suppl A): 136
CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348: 1329–1339
CAPRIE Steering Committee (1996) Double blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 340: 1421–1425
Capture Investigators (1997) Randomised Placebo-controlled trial of abciximab before and during coronary intervention in refractory instable angina: the CAPTURE study. Lancet 349: 1429–1435
CASS Principal Investigators and their Associates (1984) Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med 310: 750
CASS Principal Investigators and their Associates: Coronary Artery Surgery Study (CASS) (1983) A randomized trial of coronary artery bypass surgery. Survival data. Circulation 68: 939
CAST, The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321: 406–412
Chaitman BP, Fisher LD, Bourassa MG (1981) Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol 48: 765
Chedrawy EG, Wang JS, Nguyen DM et al. (2002) Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers: anatomic basis for functional improvements. J Thorac Cardiovasc Surg 124: 584–590
Chiu RCJ, Zibaitis A, Kao RL (1995) Cellular cardiomyoplasty: myocardial regeneration with a satellite cell implantation. Ann Thor Surg 60: 12–22
Chouka EV, Brundage BH (1993) Cardiovascular ultrafast computed tomographic angiography. Am J Cardiac Imag 7: 252–264
Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM (1994) Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 330: 1036–1040
Cohem M, Demers C, Gurfinkel EP et al. (1998) Low-molecular-weight heparins in non-ST-Segment elevation ischemia: the ESSENCE trial. Efficacy and safety of subcutaneous enoxaparin vs. intravenous unfractionated heparin, in non-Q-wave Coronary Events. Am J Cardiol 82: 19L–24L
Cohn PF (1988) Silent myocardial ischemia. Ann Intern Med 109: 312
Colhoun HM, Betteridge DJ, Durrington PN et al. for the CARDS Investigators (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicenter randomised placebo-controlled trial. Lancet 364: 685–696
Committee of Principal Investigators (1978) A cooperative trial in the prevention of ischemic heart disease using clofibrate. Br Heart J 40: 1069–1118
Conley MJ, Ely RL, Kisslo J et al. (1978) The prognostic spectrum of left main stenosis. Circulation 57: 947
Cook SL, Eigler NL, Shefer A et al. (1991) Percutaneous excimer laser coronary angioplasty of lesions not ideal for balloon angioplasty. Circulation 84: 632–643
Crouse JR, Byinton RP, Bond MG et al. (1995) Pravastatin, lipids and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 75: 455–459
Darius H, Erbel R, Belz GG, Meyer J (1992) Thrombozytenaggregationshemmer, Antikoagulanzien und Thrombolytika bei kardialen Erkrankungen. Internist 33: 670–683
Darius H, Binz C, Veit K et al. (1995) Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion. J Am Coll Cardiol 26: 800–806
Davies MJ, Thomas AC (1985) Plaque fissuring — the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 53: 363–373
Davies MJ, Bland J, Hangartner J et al. (1989) Factors influencing the presence or absence of acute coronary thrombi in sudden ischaemic death. Eur Heart J 10: 203–208
Davies MJ, Richardson PD, Woolf N et al. (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69: 377–381
Deanfield J, Wright C, Kirkler S et al. (1984) Cigarette smoking and the treatment of angina with propanolol, atenolol, and nifedipine. N Engl J Med 310: 951
Demer LL, Ariani M, Siegel RJ (1991) High intensity ultrasound increases distensibility of calcific atherosclerotic arteries. J Am Coll Cardiol 1: 1259–1262
Detre K, Peduzzi P, Murphy M et al. (1981) Effect of bypass surgery on survival in patients with low-and high-risk groups delineated by the use of simple clinical variables. Circulation 63: 1329
Deutsche Gesellschaft für Kardiologie — Herz-und Kreislaufforschung (1997) Richtlinien der interventionellen Koronartherapie. Z Kardiol 86: 1040–1063
Dietz U, Erbel R, Rupprecht H et al. (1993) High frequency rotational ablation: an alternative in treating coronary artery stenoses and occlusions. Br Heart J 70: 327–336
Dilsizian V, Bonow RO (1993) Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 87: 1–19
Dole WP (1987) Autoregulation of the coronary circulation. Prog Cardiovasc Dis 29: 293–323
Dotter CT (1969) Transluminally-placed coilspring endarterial tube grafts. Long-term patency in canine popliteal artery. Invest Radiol 4:329–332
Dotter CT, Judkins MP (1964) Transluminal treatment of arteriosclerotic obstruction: description of a new technique and a preliminary report of its application. Circulation 30: 654–670
Dotter CT, Buschmann RW, McKinney MK, Rosch J (1983) Transluminal expandable nitinol coil stent grafting: preliminary report. Radiology 147: 259–260
Downs JR, Clearfield M, Weis S et al. (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force Texas Coronary Atherosclerosis Prevention Study. JAMA 279: 1615–1622
Eastham RD, Morgan EH (1963) Plasma-fibrinogen levels in coronary-artery disease. Lancet 2: 1196
Ebers Papyrus (1990) Preface. In: Bleifeld W, Hamm CW, Braunwald E (eds) Unstable angina. Springer, Berlin Heidelberg New York
Ellis SG, da Silva ER, Heyndricks GR et al. (1994) Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 90: 2280–2284
EMERAS, Estudio multicentrico Estreptoquinasa Republicas de America del Sur (1993) Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 342: 767–772
EPIC Investigators (1994) Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. EPIC investigation. N Engl J Med 330: 956–961
Epilog Investigators (1997) Effect of the platelet glycoprotein IIb/IIIa receptor inhibitor abciximab with lower heparin dosages in ischemic complications of percutaneous coronary revascularization. N Engl J Med 336: 1689–1696
EPISTENT Investigators (1998) Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 352: 87–92
Erbel R, O’Neill W, Auth D et al. (1989a) Hochfrequenz-Rotationsatherektomie bei koronarer Herzkrankheit. Dtsch Med Wochenschr 114: 487–495
Erbel R, Pop T, Diefenbach C, Meyer J (1989b) Long-term results of thrombolytic therapy with and without percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 14: 276–285
Erbel R, Haude M, Höpp HW (1998) Coronary artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N Engl J Med 339: 1672–1678
Ernst A, Schenk EA, Gracewski SM (1991) Ability of high-intensity ultrasound to ablate human atherosclerotic plaque and minimize debris size. Am J Cardiol 68: 242–246
Espinola-Klein C, Rupprecht HJ, Erbel R et al. (1998) Impact of restenosis 10 years after coronary angioplasty. Eur Heart J 19: 1047–1053
Farb A, Tang AI, Burke AP et al. (1995) Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 92: 1701–1709
Falk E (1992) Why do plaques rupture? Circulation 86(Suppl III): 30–42
Feyter PJ de, Serruys PW (1992) Coronary angioplasty for unstable angina. Herz 17: 40–49
First International Study of Infarct Survival Colloborative Group (1986) Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-I. Lancet 2: 57–65
Fischell TA, Abbas MA, Grant GW et al. (1991) Ultrasonic energy: effects on vascular function and integrity. Circulation 84: 1783–1795
Fischman DL, Leon MB, Baim DS et al. (1994) A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331: 496–501
Fletcher AP, Alkjaersig N, Smyriotis FE, Sherry S (1958) The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Phys 71: 287
Fragmin During Instability in Coronary Artery Disease (FRISC) Study Group (1996) Low-molecular weight heparin during instability in coronary artery disease. Lancet 347: 561–568
Frick MH, Elo O, Haapa K et al. (1987) Helsinke heart study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia; Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317: 1237–1245
FTT (Fibrinolytic Therapy Trialists) Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of mortality and major morbidity results from randomized trials of more than 1000 patients. Lancet 343: 311–322
Fulton WFM (1965) The coronary arteries. Thomas Springfield III
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London) 288: 373–376
Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326: 242–250, 310-318
Gage JE, Hess OM, Murakami T et al. (1986) Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 73: 865–876
Galan KM, Deligonul U, Kern MJ et al. (1988) Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol 61: 260–263
Gao WD, Atar D, Liu Y et al. (1997) Role of Troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 80: 393–399
Geschwind HJ, Aptecar E, Boussignac G et al. (1991) Results and follow-up after percutaneous pulsed laser-assisted balloon angioplasty guided by spectroscopy. Circulation 83: 787–796
Gibbons RJ, Holmes DR, Reeder GS et al. (1993) Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 328: 685–691
GISSI, Gruppo italiano per lo studio della streptochinasi nellinfarto miocardio (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet I: 397–402
GISSI, Gruppo italiano per lo studio dello streptochinasi nellinfarto miocardio (1987) Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet II: 871
GISSI-2, Gruppo italiano per lo studio della sopravvivenza nellinfarto miocardio (1990) A factorial randomized trial of alteplase vs. streptokinase nase and heparin vs. no heparin among 14490 patients with acute myocardial infarction. Lancet 336: 65–71
Gitlin JB, Sutton JM, Casale PN et al. (1993) Transluminal extraction atherectomy: can major complications and procedural failure be anticipated? Eur Heart J 14(Suppl): 591 (Abstr)
Glagov S, Weisenberg E, Zarins CK (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316: 1371–1375
Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators (1996) A comparison of recombinant hirudin and heparin for the treatment of acute coronary syndromes. N Engl J Med 335: 775–822
Gonschior P, Höfl ing B, Mack B et al. (1993) Results of directional peripheral atherectomy with reference to histology, histochemistry, and ultrastructure. Angiology 44: 454–463
Gotto AM (1984) Practical approaches to phenotyping hyperlipoproteinemia. In: Kligfield PD (ed) Cardiology reference book. Co-Medica, New York
Gould KL, Lipscomb K, Hamilton GW (1974) Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 33: 87–94
Graham I, Mulcahy R, Hickey N et al. (1983) Natural history of coronary heart disease. A study of 586 men surviving an initial acute attack. Am Heart J 105: 249
Granger CB, Kalbfl eisch J, Califf R et al. (1991) The Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) pilot study: Combined streptokinase and t-PA. Circulation 84(Suppl II): 573
GREAT Group (1992) Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian Region Early Anistreplase Trial. Br Med J 305: 548–553
Grines CL, Nissen SE, Booth CD and the Kentucky Acute Myocardial Infarction Trial (KAMIT) Group (1991) A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Circulation 84: 540–549
Grines CL, Nissen SE, Booth CD et al. (1989) A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. J Am Coll Cardiol 14: 573–580
Grines CL, Browne KF, Marco J et al. (1993) A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328: 673–679
Grüntzig A, Kumpe DA (1979) Technique of percutaneous transluminal angioplasty with the Grüntzig balloon catheter. Am J Radiol 132:547
Grüntzig A, Kuhlmann U, Vetter W et al. (1978) Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet I: 801
Grüntzig AR, Senning A, Siegenthaler WE (1979) Non-operative dilatation of coronary artery stenosis — percutaneous transluminal coronary angioplasty. N Engl J Med 301: 61
Guidelines for coronary angiography (1987) A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures. J Am Coll Cardiol 10: 935–950
Gupta S, Leatham EW, Carrington D et al. (1997)) Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation: 96: 404–407
Gurfinkel E, Bozovich G, Daroca A, et al. (1997) Randomised trial of roxithromycin in non Q-wave coronary syndromes: ROXIS pilot study. Lancet 50: 404–407
GUSTO Investigators (1993a) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329: 673–682
GUSTO Investigators (1993b) The effects of tissue plasminogen activtor, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl Med 329: 1615–1622
Guth BD, Schulz R, Heusch G (1993) Time course and mechanisms of contractile dysfunction during acute myocardial ischemia. Circulation 87(Suppl IV): 35–42
Hafner G, Thome-Kromer B, Schaube J et al. (1994) Cardiac troponin in chronic renal failure. Clin Chem 40: 1790–1791
Haft JI, Al-Zarka AM (1993) Comparison of the natural history of irregular and smooth coronary lesions: insights into the pathogenesis, progression, and prognosis of coronary atherosclerosis. Am Heart J 126: 551–561
Hallstom AP, Cobb LA, Ray R (1986) Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 314: 271
Hamburger JN, Geert M, Gijsbers M et al. (1997) Recanalization of Chronic Total Coronary Occlusions Using a Laser Guide Wire: A Pilot Study. J Am Coll Cardiol 30: 649–656
Hamm CW, Reimers J, Ischinger T et al. for the German Angioplasty Bypass Surgery Investigation (1994) A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 331: 1037–1043
Hamm CW, Arntz HR, Bode C et al. (2004a) Leitlinien: Akutes Koronarsyndrom (ACS). Teil 1: ACS ohne persistierende ST-Hebung. Z Kardiol 93: 72–90
Hamm CW, Arntz HR, Bode C et al. (2004b) Leitlinien: Akutes Koronarsyndrom (ACS). Teil 2: ACS mit ST-Hebung. Z Kardiol 93: 324–341
Hanssen L, Zanchetti A, Carruthers SG et al. (1998) Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 351: 1755–1762
Hartzler GO, Rutherford BD, McConahay DR et al. (1983) Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 106: 965–973
Haudenschild C (1989) Pathogenesis of restenosis. Z Kardiol 78(Suppl 3): 28–34
Häußel CP, Voigtländer T, Kauczor HU et al. (1997) Spiral CT zum Nachweis von Koronararterienverkalkungen und Vorhersage einer koronaren Herzerkrankung — Vergleich zur Durchleuchtung und Koronarangiographie. Fortschr Röntgenstr 167: 16–23
Heberden W (1786) Some account of a disorder of the brest. Med Trans R Coll Physicians II: 59
Heidbüchl H, Tack J, Vanneste L et al. (1994) Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a β-blocker or a bradycardiac agent of their incidence. Circulation 89: 1051–1059
Heijer P den, Dijk RB van, Pentinga ML et al. (1992) Laser thrombolysis: first clinical results. Eur Heart J 13(Suppl): 15
Held PH, Yusuf S, Furberg CD (1989) Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 2: 1187
Henderson WG, Goldman S, Copeland JG et al. (1989) Antiplatelet or anticoagulant therapy after coronary artery bypass surgery. A metaanalysis of clinical trials. Ann Intern Med 111: 743
Heusch G (1990) β-adrenergic mechanisms in myocardial ischemia. Circulation 81: 1–13
Heusch G (1991) The relationship between regional blood flow and contractile function in normal, ischemic, and reperfused myocardium. Basic Res Cardiol 86: 197–218
Heusch G (1998) Hibernating mycoardium. Physiol Rev 78: 1055–1085
Hinohara T, Selmon MR, Robertson GC et al. (1990) Directional atherectomy: new approaches for treatment of obstructive coronary and peripheral vascular disease. Circulation 81(Suppl IV): 79–91
Höher M, Kotzerke J, Wöhrle J et al. (2001) Intracoronary β-irradiation with liquid rhenium-188 to prevent restenosis following angioplasty of de-novo and restenotic lesions — results from the randomized ECRIS II trial. Eur Heart J 22(Suppl): 5
Holmes DR Jr, Bates ER, Viluman NS et al. (1995) Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 26: 668
Hör G (1988) Myocardial scintigraphy 25 years after start. Eur J Nucl Med 13: 619–636
Hör G, Standke R, Klepzig H Jr et al. (1986) Äquilibrium-Radionuklid-Ventrikulographie: Vergleich mit Echokardiographie und digitaler Subtraktionsangiographie; Multi-Parameterbewertung. Nuklearmediziner 9: 211–234
Hort W (1965) Ventrikeldilatation und Muskelfaserdehnung als früheste morphologische Befunde beim Herzinfarkt. Virchows Arch 339: 72–82
Hort W (1990) Morphological aspects. In: Jacob R, Seipel L, Zucker HJ (eds) Cardiac dilatation. Fischer, Stuttgart, pp 3–17
Hort W (1994) Pathologische Anatomie der Herzinsuffizienz. In: Griebenow R et al. (Hrsg) Autonomes Nervensystem und Herz. Thieme, Stuttgart
Hort W (Hrsg) (2000) Pathologie des Endokard, der Kranzarterien und des Myokard. Springer, Berlin Heidelberg New York
Hort W (2002) Inner layer infarction of the coronary artery wall due to coronary thrombosis. Virchows Arch 441: 490–493
Hort W, Lichti H, Kalbfleisch H et al. (1982) The size of human coronary arteries depending on the physiological and pathological growth of the heart in age, the size of supplying areas and the degree of coronary sclerosis. A postmortem study. Virchows Arch 397: 37–59
HPS Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised lacebo-controlled trial. Lancet 360: 7–22
Hueb WA, Bellotti G, de Oliveira SA et al. (1995) The medicine, angioplasty, or surgery Study MASS: A prospective randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 26: 1600–1605
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction; ISIS-2. Lancet II: 348–360
ISIS-3 (Third International Study of Infarct Survival) Collaborative Group:ISIS-3 (1992) A randomized comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41299 cases of suspected acute myocardial infarction. Lancet 339: 753–770
ISIS-4 (1995) A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58.050 patients with suspected acute myocardial infarction. Lancet 345: 669–685
Jennings RB, Murry CE, Reimer KA (1991) Preconditioning myocardium with ischemia. Cardiovasc Drugs Ther 5: 933–938
Johnson LL, Sedlin DW (1989) The role of antimyosin antibodies in acute myocardial infarction. Semin Nucl Med 19: 238–246
Judkins MP (1967) Selective coronary arteriography. I. A percutaneous transfemoral technique. Radiology 89: 815
Jukema JW, Bruschke AVG, Van Boven AJ et al. (1995) Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. Circulation 91: 2528–2540
Jungbluth A, Düber C, Rumpelt HJ et al. (1988) Koronararterienmorphologie nach perkutaner transluminaler Koronarangioplastie (PTCA) mit Hämoperikard. Z Kardiol 77: 125–129
Jurt U, Gori T, Ravandi A et al. (2001) Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. J Am Coll Cardiol 38: 854–859
Juul-Möller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R for the Swedish Angina Pectoris Aspirin Trial (SAPAT) (1992) Doulbeblind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 340: 1421–1425
Kalbfleisch H, Hort W (1976) Die Verteilungsmuster (Versorgungstypen) des menschlichen Herzens. Postmortale Untersuchungen. Dtsch Med Wochenschr 101: 1092–1097
Kannel WB, Feinlieb M (1972) Natural history of angina pectoris in the Framingham Study: Progress and survival. Am J Cardiol 29: 154
Kannel WB, Castelli WP, Gordon T (1979) Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 90: 85–91
Katus HA, Remppis A, Neumann FJ et al. (1991) Diagnostic efficiency of troponin T measuremants in acute myocardial infarction. Circulation 83: 902–912
Kawai C (1994) Pathogenesis of acute myocardial infarction. Novel regulatory systems of bioactive substances in the vessel wall. Circulation 90: 1033–1043
Kellermann JJ, Braunwald E (1990) Silent myocardial ischemia: A critical appraisal. Karger, Basel
Kereiakes D, Moses JW, Leon MB et al. (2003). Durable clinical benefit following CYPHER coronary lowing CYPHER coronary stent deployment: SIRIUS study 2-year results. Circulation 108(Suppl IV): 532A
King SB III, Lembo NJ, Weintraub WS et al. for the Emory Angioplasty vs. Surgery Trial (EAST) (1994) A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 331: 1044–1050
King SB III, Williams DO, Chougule P et al. (1998) Endovascular β-radiation to reduce restenosis after coronary balloon angioplasty. Results of the Beta Energy Restenosis Trial (BERT). Circulation 97: 2025–2030
Kirklin JW, Naftel DC, Blackstone EH, Pohost GM (1989) Summary of a consensus concerning death and ischemic events after coronary artery bypass grafting. Circulation 79(Suppl I): 81
Kol A, Sukhova GK, Lichtman AH et al. (1998) Chlamydial heat shock protein 60 localises in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98: 300–307
Kramer JR, Proudfit WL, Loop FD et al. (1989) Late follow-up of 781 patients undergoing percutaneous transluminal coronary angioplasty or coronary artery bypass grafting for an isolated obstruction in the left anterior descending coronary artery. Am Heart J 118: 1144
Kronmal RA, Oberman A, Frye RL, Killip T III (1986) Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from CASS registry. JAMA 255: 1023
Kropp J (1992) Szintigraphie mit J-123-markierten Fettsäuren zur Diagnostik der KHK. Nuklearmediziner 15: 185–194
Kuntz RE, Safian RD, Levine MJ et al. (1992) Novel approach to the analysis of restenosis after the use of three new coronary devices. J Am Coll Cardiol 19: 1493–1499
Laitinen K, Laurila A, Pyhala L et al. (1997) Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 65: 4832–4835
Lee SH, Wolf PL, Escudero R (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342: 626–633
Leon MB, Baim DS, Gordon P et al. (1996) Clinical and angiographic results from the stent anticoagulation regiment study (STARS). Circulation 94(Suppl I): 685
Lewis HD, Davis JW, Archibald DG et al. (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 309: 396–403
Lichtlen PR, Hugenholtz PG, Rafflenbeul W et al. (1990) Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the international nifedipine trial on antiatherosclerotic therapy. Lancet 335: 1109
Lim H, Falloavollita JA, Hard R et al. (1999) Profund apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium. Circulation 100: 2380–2386
Linder L, Kiowski W, Bühler FR, Lüscher TF (1990) Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 81: 1762–1767
Long-term intervention with pravastatin in ischemic disease of lipidstudy group (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339: 1349–1357
Maass M, Bartels C, Engel PM, et al. (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. Jam Coll Cardiol 31: 827–832
MacMahon S, Collins R, Peto R, Koster RW, Yusuf S (1988) Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized controlled trials. JAMA 260: 1910–1916
Manning W, Li W, Edelman RR (1993) A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. N Engl J Med 328: 828–832
Manz M, Mletzko R, Jung W, Lüderitz B (1992) Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of substained ventricular tachycardia. Eur Heart J 13: 1123–1128
Margolis JR, Kannel WB, Feinlieb M et al. (1973) Clinical features of unrecognized myocardial infarction — silent and symptomatic. Eighteen year follow-up:The Framingham Study. Am J Cardiol 32: 1–7
Mathey DG, Rodewald G, Rentrop P et al. (1981) Intracoronary streptokinase thrombolytic recanalization and subsequent surgical bypass of remaining atherosclerotic stenosis in acute myocardial infarction: complementary combined approach effecting reduced infarct size, preventing reinfarction, and improving left ventricular function. Am Heart J 102(Suppl): 1194–1201
Meinertz T, Kasper W, Schumacher M et al. (1988) The German multicenter trial of anisoylated plasminogen activator complex vs. heparin for acute myocardial infarction. Am J Cardiol 62: 347
Meyer J, Merx W, Dörr R et al. (1982a) Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary revascularization (PTCR) and percutaneous transluminal coronary angioplasty (PTCA). Am Heart J 103: 132–134
Meyer J, Merx W, Erbel R et al. (1982b) Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation 66: 905–913
Moazed TC, Kuo CC, Patton DL et al. (1996) Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol 148: 667–76
Mock MB, Ringqvist I, Fisher LD et al. (1982) Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 66: 562–566
Moncada S, Gryglewski RJ, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663–665
Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142
Monreal M, Lafoz E, Olive A et al. (1994) Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thomb Haemost 71: 7–11
Muhlestein JB, Hammond EH, Carlquist JF et al. (1996) Incrased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic vs. other forms of cardiovascular disease. J Am Coll Cardiol 27: 1555–1561
Muhlestein JB, Anderson JL, Hammond EH et al. (1998) Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97: 633–636
Muller-Leise CR, Schmitz-Rode T, Boehm N et al. (1991) US-angioplasty: experimental in vitro penetration of fibrous and calcified atherosclerotic plaques. Radiol Soc North Am 181: 170
Multicenter Diltiazem Postinfarction Research Group (1988) The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 319: 385–392
Murad F (1994) The role of nitric oxide in modulating guanylyl cyclase. Neurotransmissions 10: 1–4
National center for health statistics (1999) Health United States 1996. Public Health Service, Hyattsville, Maryland
Neuhaus KL, Tebbe U, Gottwik M et al. (1988) Intravenous recombinant tissue plasminogen activator (t-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS). J Am Coll Cardiol 12: 581–587
Nothnagel H (1905) Letzte Niederschrift: Bemerkungen über seine stenokardischen Anfälle. Dtsch Med Wochenschr 39: 1564–1565
Nowak B, Voigtländer T, Bärenfänger P et al. (1994) Temporary single lead VDD-pacing under intensive care conditions:sensing thresholds and feasibility. Pacing Clin Electrophysiol 17:867
Ojio S, Takatsu H, Tanaka T et al. (2000) Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans. Circulation 102: 2063–2069
Opie LH (1992a) Cardiac metabolism — emergence, decline, and resurgence. Cardiovasc Res 26: 721–733
Opie LH (1992b) Cardiac metabolism — emergence, decline, and resurgence. Part II. Cardiovasc Res 26: 817–830
Palmaz JC, Sibbit RR, Reuter SR et al. (1985) Expandable intraluminal graft: a preliminary study. Radiology 156: 73–77
Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526
Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE (1990) Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22–27
Parisi AF, Folland ED, Hartigan P and the ACME Investigators (1992) A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 326: 10–16
Parker JD, Parker JO (1998) Nitrate therapy for stable angina pectoris. N Engl J Med 338: 520–31
Peduzzi P, Detre K, Murphy ML (1991) Ten-year incidence of myocardial infarction and prognosis after infarction: department of Veterans Affairs Cooperative study of coronary artery bypass surgery. Circulation 83: 747
Pekkanen J, Linn S, Heiss G et al. (1990) Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 322: 1700–1717
PET-Arbeitsgrupe/Arbeitskreis Nuklearradiologie (1996) Indikationen für die klinische Anwendung der Positronen-Emissions-Tomographie in der Kardiologie. Z Kardiol 85: 453–468
Pfeffer MA et al. (1992) Effect of captopril on mortality and morbitity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327: 669–677
Pitt B, Mancini GBJ, Ellis GS et al. (1995) Pravastatin limitation of atherosclerosis in the coronary arteries (PLACI): Reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol 26: 1133–1139
Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators (1998) A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 338: 1498–1505
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators (1998) Inhibition of the platelet glycoprotein IIb/IIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 338: 1488–1497
Pocock SJ, Henderson RA, Rickards AF et al. (1995) Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 356: 1181–1189
Popma JJ, Dehmer GJ (1989) Care of the patient after coronary angioplasty. Ann Intern Med 110: 547
PRIMI Trial Study Group (1989) Randomized double-blind trial of recombinant prourokinase against streptokinase in acute myocardial infarction. Lancet 1: 863–868
Proudfit WL, Kramer JR, Goormastic M, Loop FD (1988) Survival of patients with mild angina or myocardial infarction without angina; a comparison of medical and surgical treatment. Br Heart J 59: 641
Pryor DB, Harrell FE Jr, Lee KL et al. (1983) An improving prognosis over time in medically treated patients with coronary artery disease. Am J Cardiol 52: 444
Pursuit Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 339: 436–443
Rahimtoola SH (1989) The hibernating myocardium. Am Heart J 117: 211–221
Reig J, Jornet A, Petit M (1993) Segmentary analysis of the coronary artery distribution in the left ventricle. Surg Radiol Anat 15: 91–97
Reinecke P, Hort W (1992) Untersuchungen über das Wachstum der Koronararterienäste beim Menschen unter physiologischen Bedingungen. Morphologische Untersuchungen an Korrosionspräparaten des R. interventricularis anterior. Z Kardiol 81: 110–115
RESTORE Investigators (1997) Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 96: 1445–1453
Richardson PD, Davies MJ, Born GVR (1989) Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 941–944
Richtlinien zur Einrichtung und zum Betreiben von Herzkatheterräumen (1994) Z Kardiol 83: 525–528
Ridker PM, Manson JE, Gaziano JM et al. (1991) Low-dose aspirin therapy for chronic stable angina. A randomized clinical trial. Ann Intern Med 114: 835
RISC Group (1990) Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 336: 827–830
RITA Trial Participants (1993) Coronary angioplasty vs. coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet 341: 573–580
Roberts R et al. (1991) Immediate vs. deferred beta blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction trial (TIMI)-IIBstudy. Circulation 83: 422–437
Roelandt JRTC, diMario C, Pandian NG et al. (1994) Three-dimensional reconstruction of intracoronary ultrasound images — Rationale, approaches, problem, and directions. Circulation 90: 1044–1055
Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S (1985) The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 313: 1511–1514
Rosenschein U, Bernstein JJ, DiSegni E et al. (1990) Experimental ultrasonic angioplasty: disruption of atherosclerotic plaques and thrombi in vitro and arterial recanalization in vivo. J Am Coll Cardiol 15: 711–717
Rosenschein U, Rozenszajn LA, Kraus L et al. (1991) Ultrasonic angioplasty in totally occluded peripheral arteries. Circulation 83: 1976–1986
Ross J Jr (1991) Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. Circulation 83: 1076–1083
Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809
Rost R (1998) Ambulante vs. stationäre Rehabilitation nach stattgehabtem Myokardinfarkt — Pro ambulante Rehabilitation. Z Kardiol 87(Suppl 2): 222–224
Rowe MH, Hinohara T, White NW et al. (1990) Comparison of dissection rates and angiographic results following directional coronary atherectomy and coronary angioplasty. Am J Cardiol 66: 49–53
Rubartelli P, Niccoli L, Verna E (1998) Stent implantation vs. balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial. J Am Coll Cardiol 32: 90–96
Rumberger JA, Sheedy PF, Breen JF et al. (1996) Electron beam computed tomography and coronary artery disease: scanning for coronary artery calcification. Mayo Clin Proc 71: 369–377
Rupprecht HJ, Hamm C, Ischinger T et al. on behalf of the GABI Study Group (1996) Angiographic follow-up results of a randomized study on angiopalsty vs. bypass surgery (GABI trial) Eur Heart J 17: 1192–1198
Rupprecht HJ, Darius H, Borkowski U et al. (1998a) Comparison of Antiplatelet Effects of Aspirin, Ticlopidine, or Their Combination After Stent Implantation. Circulation 97: 1046–1052
Rupprecht HJ, Espinola-Klein C, Erbel R et al. (1998b) Impact of routine angiographic follow-up after angioplasty. Am Heart J 136: 613–619
Ryan TF, Faxon DP, Gunnar RM et al. (1988) Guidelines for percutaneous transluminal coronary angioplasty — A report of the ACC/AHA Task Force on assessment of diagnostic and therapeutic cardiovascular procedures. J Am Coll Cardiol 12: 529
Sacks FM, Pfeffer MA, Moye L et al. (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335: 1001–1009
Saikku, P, Leinonen M, Tenkanen L et al. (1992) Chronic Chlamydia pneumonia infectionas a risk factor for coronbary heart disease in the Helsinki heart study. Ann Intern Med 116: 273–278
Salonen R, Nyyssonen K, Porkkala E et al. (1995) Kuopio Atherosclerosis Prevention Study (KAPS): a population-based primary preventive trial of the effect of LDL-lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 92: 1758–1764
Samani NJ, Boultby R, Butler R (2001) Telomere shortening in atherosclerosis. Lancet 358: 472–473
Savage MP, Douglas JS, Fischman DL et al. (1997) Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts (SAVED Trial) N Engl J Med 337: 740–747
Scandinavian Simvastatin Survival Study (1994) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383–1389
Scandinavian Simvastatin Survival Study (1995) Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet 345: 1274–1275
SCATI-Group (1989) Randomized controlled trial of subcutaneous calcium-heparin in acute myocardial infarction. Lancet II, 182–186
Schaper W (1991) Angiogenesis in the adult heart. Basic Res Cardiol 86(Suppl 2): 51–56
Schaper W (1996) Molecular mechanisms of coronary collateral vessel growth. Circ Res 79: 911–919
Schaper W, Görge G, Winkler B, Schaper J (1988) The collateral circulation of the heart. Prog Cardiovasc Dis 31: 57–77
Schelbert HR (1987) Current status and prospects of new radionuclides and radiopharmaceuticals for cardiovascular nuclear medicine. Nucl Med 17: 145–181
Schlant RC, ORourke RA, Collen D et al. (1994) Reperfusion in acute myocardial infarction. Circulation 90: 2091–2102
Schmermund A, Baumgart D, Adamzik M et al. (1998) Relative frequency of calcified and non-calcified plaques in patients with acute coronary syndromes and no or minimal to moderate angiographic disease: insights from the combination of intracoronary ultrasound and electron beam CT. Am J Cardiol 81: 141–146
Schömig A, Neuman FJ, Kastrati A et al. (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 334: 1084–1089
Schulz R, Guth BD, Pieper K et al. (1992) Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery: a model of short-term hibernation. Circ Res 70: 1282–1295
Schulz R, Rose J, Martin C et al. (1993) Development of short-term myocardial hibernation: its limitation by the severity of ischemia and inotropic stimulation. Circulation 88: 684–695
Schwarz ER, Patterson M, Kloner RA (1998) Kardiomyozytentransplantation — eine Frischzellenkultur zur Gewebsreparatur in infarzierten Herzen? Z Kardiol 87: 1–7
Serruys PW, Strauss BJ, Beatt KJ et al. (1991) Angiographic follow-up after a self-expanding coronary-artery stent. N Engl J Med 324: 13–17
Serruys PW, de Jaegere P, Kiemeneij F et al. (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331: 489–495
Serruys PW, van Hout B, Bonnier H et al. (1998) Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (BENESTENT ll). Lancet 352: 673–681
Sever P, Dahlhöf B, Poulter N et al. for the ASCOT Investigators (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial — Lipid Lowering Arm (ASCOT-LLA): a multicenter randomised controlled trial. Lancet 361: 1149–1158
Shepherd J, Cobbe SM, Ford I et al. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301–1307
Siegel RJ, Ariani M, Forrester JS et al. (1989) Cardiovascular applications of therapeutic ultrasound. J Invasive Cardiol 1: 219–229
Siegel RJ, Don Michael TA, Fishbein MC et al. (1990) In vivo ultrasound arterial recanalization of atherosclerotic total occlusions. J Am Coll Cardiol 15: 345–351
Sigwart U, Puel J, Mirkovitch V et al. (1991) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316: 701–706
Silver MA (1986) Morphologic substrates of ventricular arrhythmias. Clin Prog Electrophysiol Pacing 4: 1–13
Simoons ML, Arnold AE, Betriu A et al. (1988) Thrombolysis with tissue plasminogen activator in acute myocardial infarction: No beneficial effects of immediate PTCA. Lancet I: 197–203
Simoons ML, Vos J, Tijssen JGP et al. (1989) Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5-year follow-up of a trial conducted by the Interuniversity Cardiology Committee, University of the Netherlands. J Am Coll Cardiol 14: 1609
Simpson JB, Baim DS, Robert EW, Harrison DC (1982) A new catheter system for coronary angioplasty. Am J Cardiol 49: 1216
Simpson JB, Selmon MR, Robertson GC et al. (1988) Transluminal atherectomy for occlusive peripheral vascular disease. Am J Cardiol 61: 96G–101G
Sinapius D (1965) Über Wandveränderungen bei Coronarthrombose, Bemerkungen zur Häufigkeit, Entstehung und Bedeutung. Klin Wochenschr 43: 875–880
Sirnes PA, Svein G, Myreng Y et al. (1998) Sustained benefit of stenting chronic coronary occlusion: long-term clinicial follow-up of the stenting in chronic coronary occlusion (SICCO) study. J Am Coll Cardiol 32: 305–310
Smith P et al. (1990) The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990: 147–152
Sones FM, Shiley EK (1962) Cine coronary arteriography. Mod Concepts Cardiovasc Dis 31: 735
Spiecker M, Erbel R, Rupprecht HJ, Meyer J (1994) Emergency angioplasty of totally occluded left main coronary artery in acute myocardial infarction and unstable angina pectoris — institutional experience and literature review. Eur Heart J 15: 602–607
Stamler JD, Wentworth D, Neaton JD (1986) Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356.222 primary screens of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256: 823–828
Stary HC, Chandler AB, Dinsmore RE et al. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on atherosclerosis. Amer Heart Assoc. Arterioscler Thromb Vasc Biol 15: 1512–1531
Statistisches Bundesamt (1999) Publikationen des Bundesamtes in Wiesbaden Steering Committee (1996) A randomized, blinded trial of clopidogrel vs. aspirin in patients at risk of ischemic events (CAPRIE). Lancet 348: 1329–1339
Steering Committee of the Physicians Health Study Research Group (1989) Final report on the aspirin component of the ongoing Physicians Health Study. N Engl J Med 321: 129–135
Steffen W, Luo H, Fishbein MC et al. (1993) Catheter delivered therapeutic ultrasound recanalizes thrombotically occluded coronary arteries in vivo: a canine study. J Am Coll Cardiol 21: 76A
Stone GW, Grines CL, Browne KF et al. (1995) Predictions of in-hospital and 6 month outcome after acute myocardial inarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol 25: 370–377
Stone GW, Ellis SG, Cox DA et al. (2003) The pivotal US study of the slowrate release polymer-based Paclitaxel-eluting TAXUS stent in patients with de novo coronary lesions: 1-year clinical results of the TAXUS-IV trial. Circulation 108(Suppl IV): 533
Strauer BE, Brehm M, Zeus T et al. (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913–1921
Strunk H, Weber W, Steffen W et al. (1992) Percutaneous sonographic angioplasty: initial experimental results. Rofo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der neuen bildgebenden Verfahren 156: 33–36
Suryapranata H, Arnoud WJ, Hoornje JCA et al. (1998) Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocadial infarction. Circulation 97: 2502–2505
Sutton JM, Gitlin JB, Casale PN et al. (1992) Major complications after TEC atherectomy: preliminary analysis derived from the multicenter registry experience. Circulation 86: 456
Sutton JM, Gitlin JB, Casale PN et al. (1993) Complex lesions with ulceration or calcification are predictors of restenosis after transluminal extraction atherectomy. J Am Coll Cardiol 21:442A
Swan HJC, Ganz W, Forrester JS et al. (1970) Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 283: 447–451
Tardif JC, Cote G, Lespèrance J et al. (1997) Probucol and multivitamins in the prevention of restenosis after coronary angiopalsty. N Engl J Med 337: 365–372
Teirstein PS, Massullo V, Shirish-Jani et al. (1997) Catheter based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 336: 1697–1703
Telford AM, Wilson C (1981) Trial of heparin vs. atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet I: 1225–1228
Tenaglia AN, Buller CE, Kisslo KB et al. (1992) Mechanisms of balloon angioplasty and directional coronary atherectomy as assessed by intracoronary ultrasound. J Am Coll Cardiol 20: 685–691
Tillett WS, Garner RI (1933) The fibrinolytic activity of hemolytic streptococci. J Exp Med 58: 485–502
TIMI IIIB Trial (1994): Thrombolysis in Myocardial Ischemia. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 89: 1545–1556
TIMI Research Group (1988) Immediate vs. delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. JAMA 260: 2849–2858
TIMI Study Group (1989) Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. N Engl J Med 320: 618–627
Topol EJ (1994) Thrombolytic intervention. In: Topol EJ (ed) Textbook of Interventional Cardiology, 2nd edn. Saunders, Philadelphia, pp 68–111
Topol EJ, Bell WR, Weisfeldt ML (1985a) Coronary thrombolysis with recombinant tissue-type plasminogen activator: a hematologic and pharmacologic study. Ann Intern Med 103: 837–843
Topol EJ, Ciuffo AA, Pearson TA et al. (1985b) Thrombolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusion. J Am Coll Cardiol 5: 85–91
Topol EJ, Bates ER, Walton JA et al. (1987a) Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function. J Am Coll Cardiol 10: 1173–1177
Topol EJ, Califf RM, George BS et al. (1987b) A randomized trial of immediate vs. delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infaction. N Engl J Med 317: 197–202
Topol EJ, Ellis SG, Fishman J et al. (1987c) Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis. J Am Coll Cardiol 9: 1214–1218
Topol EJ, Califf RM, George BS et al. (1988) Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction (TAMI-2). Circulation 77: 1100–1107
Topol EJ, Leya F, Pinkerton CA et al. (1993) A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 329: 221–227
Topol EPIC-Studie Lancet (1994) Topol EJ, Califf RM, Weisman HF et al. (1994) Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. Lancet 343: 881–886
Topol EPIC-Studie (1994) The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in N Engl J Med 330: 956–961
Topol EJ, Serruys PW (1998) Frontiers in Interventional Cardiology. Circulation 98: 1802–1820
Tunstall-Pedoe H, Kuulasmaa K, Amougel P et al. (1994) Myocardial infarction and coronary deaths in the World Health Organisation MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90: 583–612
Turpie AGG, Robinson JG, Doyle DJ et al. (1989) Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med 320, 352–357
Ueda M, Becker AE, Tsukada T (1991) Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation 83: 1327–1332
UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and mircrovascular complictions in type 2 diabetes: UKPDS 38. Brit Med J 317: 703–720
URALMI, Urokinase and Alteplase in Myocardial Infarction Collaborative Group (1991) Combination of urokinase and alteplase in the treatment of myocardial infarction. Coron Artery Dis 2: 225–235
Urban P, Macaya C, Rupprecht HJ (1998) Randomized evaluation of anticoagulation vs. antiplatelet therapy after coronary stent implantation in high-risk patients (the multicenter aspirin and ticlopidine trial after intracoronary stenting; MATTIS, 1998). Circulation 98: 2126–2132
Van Belle E, Bauters C, Hubert E et al. (1997) Restenosis rates in diabetic patients. A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96: 1454–1460
Vanhoutte PM, Scott-Burden T (1994) The endothelium in health and disease. Texas Heart Inst J 21: 62–67
Veinot JP, Gattinger DA, Fliss H (1997) Early apoptosis in human myocardial infarcts. Hum Pathol 28: 485–492
Versaci F, Gaspardone A, Tomai, F (1997) A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 336: 817–822
Verschuren WWM, Jacobs DR, Bloemberg BPM et al. (1995) Serum total cholesterol and long-term coronary heart disease mortality in different cultures: Twenty-fi ve-year follow-up of the seven countries study. JAMA 274: 131–136
Virmani R, Farb A, Carter AJ, Jones RM (1999) Pathology of radiation-induced coronary artery disease in human and pig. Cardiovasc Radiat Med 1: 98–101
Voigtländer T, Nowak B, Bärenfänger P et al. (1997) Feasibility and sensing thresholds of temporary single-lead VDD pacing in intensive care. Am J Cardiol 1997 79: 1360–1363
Waksman R, White L, Chan RC et al. (2000) Intracoronary-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 101: 2165–2171
Wallentin LC and the Research Group on Instability in Coronary Artery Disease in Southeast Sweden (1991) Aspirin (75mg/day) after an episode of unstable coronary artery disease: long term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. J Am Coll Cardiol 18: 1587–1593
Waller BF, Pinkerton CA, Orr CM et al. (1991) Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients. J Am Coll Cardiol 17: 58B–70B
Warburton R, Tampas J, Soule A, Taylor H (1968) Coronary artery calcification: its relationship to coronary artery stenosis and myocardial infarction. Radiology 91: 105–115
Warkentin TE, Levine MN, Hirsh J et al. (1995) Heparin-induced thombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332: 1330–1335
Weaver WD, Cerqueira M, Hallstrom AP for the MITI Project Group (1993) Early treatment with thrombolytic therapy: results from the Myocardial Infarction, Triage and Intervention Pre-Hospital Trial. JAMA 270: 1211–1216
Weaver WD, Simes RJ, Betriu A et al. (1997) Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 278: 2093–3098
Weintraub WS, Ghazzal ZMB, Cohen CL et al. (1991) Clinical implications of late proven patency after successful coronary angioplasty. Circulation 84: 572
White CJ, Ramee SR, Mesa JE, Collins TJ (1991) Percutaneous coronary angioscopy in patients with restenosis after coronary angioplasty. J Am Coll Cardiol 17: 46B–49B
White HD, Cross DB, Elliott JM et al. (1994) Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 89: 61–67
Whitlow PL, Buchbinder M, Kent K et al. (1992) Coronary rotational atherectomy: angiographic risk factors and their relation to success/ complications. J Am Coll Cardiol 19: 334A
Whittacker P, Bougner DR, Kloner RA, Przyklenk K (1991) Stunned myocardium and myocardial collagen damage: differential effects of single and repeated occlusions. Am Heart J 121: 434–441
Wilcox RG for the LATE Steering Committee (1993) Late assessment of thrombolytic efficacy with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 342: 759–766
Wong YK, Gallagher PJ, Ward ME (1999) Chlamydia pneumonia and atherosclerosis. Heart 81: 232–238
Wood MA de, Spores J, Notske RN et al. (1979) Medical and surgical management of myocardial infarction. Am J Cardiol 4: 1356–1364
Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators (1997) Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. JAMA 277: 715–721
Xu Q, vWilleit J, Marosi M, et al. (1993) Association of serum antibodies to heat shock protein 65 with carotid atheroslerosis. Lancet 342: 225–229
Zeiher AM, Drexler H, Saurbier B, Just H (1993) Endothelium-mediated coronary blood fl ow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 92: 652–662
Zeitler E, Schoop W, Zahnow W (1971) The treatment of occlusive arterial disease by transluminal catheter angioplasty. Radiology 99: 19
Zhao M, Sonnenblick EH, Zhang H, Eng C (1992) Increase in myofi lament separation in the »stunned« myocardium. J Mol Cell Cardiol 24: 269–276
Zijlstra F, Boer MJ de, Hoorntje CA et al. (1993) A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328: 680–684
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Meyer, J. et al. (2006). Koronare Herzkrankheit und Herzinfarkt. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29425-2_2
Download citation
DOI: https://doi.org/10.1007/3-540-29425-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23742-6
Online ISBN: 978-3-540-29425-2
eBook Packages: Medicine (German Language)